Results 41 to 50 of about 3,737,366 (186)
Immunotherapy of biliary tract cancer
Tumor Biology, 2016 Biliary tract cancers (BTCs), which encompass intra- and extrahepatic cholangiocarcinomas as well as gallbladder carcinomas, are one of the most aggressive malignancies. Although the development of systemic chemotherapy approaches has made progress, the prognosis of BTC remains poor. Chronic inflammation plays an important role in the carcinogenesis of
openaire +2 more sources
Capecitabine Extends Survival for Biliary Tract Cancer
, 2017 Based on results of the phase III BILCAP study, adjuvant capecitabine should become standard treatment for patients with biliary tract cancer. Among 430 patients who were treated according to the study protocol, capecitabine was associated with a 25 ...
core +1 more source
Helicobacter pylori and Biliary Tract Cancers: A Meta-Analysis
Canadian Journal of Infectious Diseases and Medical Microbiology, 2020 Background. Helicobacter pylori is detected in various extragastric diseases, including biliary tract cancers. Besides, gallbladder cancers, extracholangiocarcinomas, and intracholangiocarcinomas are highly lethal cancers with limited survival due to ...
Soumia Cherif +4 more
doaj +1 more source
Chemotherapy for Biliary Tract Cancer
The Korean Journal of Gastroenterology, 2017 The term of biliary tract cancer (BTC) refers to all tumors that arise from the biliary tract or the biliary drainage system, including the intra- and extra-hepatic bile ducts as well as the gallbladder. BTCs are aggressive tumors with limited treatment options and poor overall survival.
openaire +3 more sources
Bile acid analysis in biliary tract cancer [PDF]
, 2006 The etiology of biliary tract cancer is obscure, but there are evidences that bile acid plays a role in carcinogenesis. To find the association between biliary tract cancer and bile acid, this study compared the bile acid concentration and composition ...
고준상 +5 more
core +1 more source
Survival of patients with primary liver cancer, pancreatic cancer and biliary tract cancer in Europe
, 1998 cancer survival - liver cancer- pancreatic cancer - biliary tract ...
FAIVRE J. +6 more
core +1 more source
npj Precision Oncology, 2022 Immunotherapies have been explored in treating solid tumors, albeit with disparate clinical effects in distinct cancer types. Systematic interrogation of immune cells in the tumor microenvironment (TME) is vital to the prediction of immunotherapy ...
Xuebing Shi +19 more
doaj +1 more source
Precision Oncology Targets in Biliary Tract Cancer
, 2023 Targeted therapies in biliary tract cancer (BTC) are emerging as options for patients not who do not respond to first-line treatment. Agents acting on tumor-specific oncogenes in BTC may target fibroblast growth factor receptor 2 (FGFR2), isocitrate ...
Nicole Farha +3 more
core +1 more source
, 2022 Supplementary Figure from Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated By Gemcitabine-Based ...
Shalini Makawita (7515581) +11 more
core +2 more sources
Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
, 2021 Biliary tract cancer (BTC) includes a heterogeneous group of aggressive and rare hepatobiliary malignancies, including gallbladder cancer, ampullary carcinomas, intrahepatic cholangiocarcinoma (iCCA), and extrahepatic cholangiocarcinoma, further ...
Angela Dalia Ricci, Alessandro Rizzo
core +1 more source